Printer Friendly

MEDISCIENCE TECHNOLOGY CORP. SIGNS COBY CAPITAL CORPORATION AS FINANCIAL ADVISOR

 CHERRY HILL, N.J., Dec. 10 /PRNewswire/ -- Mediscience Technology Corp. (NASDAQ: MDSC.U), developer and designer of non-invasive technology used in medical diagnostic instruments that detect cancer based upon differentiations in the amount of light re-emitted from malignant and benign tissue, today announced the engagement of Coby Capital Corporation of Stamford, Conn., as its financial advisor.
 Peter Katevatis, president of Mediscience, also announced that agreement had been reached with Coby Capital under which Coby Capital would use its best efforts to raise $4 to $6 million for the company in a private in a private placement of the company's equity securities.
 -0- 12/10/93 R
 /CONTACT: Peter Katevatis, president, 609-428-7952 or Ronald Krumm, vice president, 516-484-9141, both of Mediscience/
 (MDSC.U)


CO: Mediscience Technology Corp; Coby Capital Corporation ST: New Jersey IN: MTC SU:

GK -- NY012R -- 2517 12/10/93 09:18 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 10, 1993
Words:144
Previous Article:APPLE EXTENDS QUICKTIME MULTIMEDIA STANDARD; APPLE DEMONSTRATES QUICKTIME WORKING WITH MPEG DIGITAL VIDEO
Next Article:BB&T ANNOUNCES TERMINATION OF PLANS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters